Kyoichi Okishio

Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study

Luis Paz‐Ares, Óscar Juan, Giannis Mountzios et al. · Journal of Clinical Oncology · 2024 · 115 citations · Full text

Medicine, Oncology, Pharmacology +17

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Beyond Progressive Disease: A Retrospective Analysis for Japanese Patients with Activating EGFR Mutations

Kenichi Nishie, Tomoya Kawaguchi, Akihiro Tamiya et al. · Journal of Thoracic Oncology · 2012 · 107 citations

Medicine, Oncology, Pharmacotherapy +12

Cerebrospinal Fluid Penetration Rate and Efficacy of Afatinib in Patients with EGFR Mutation-positive Non-small Cell Lung Cancer with Leptomeningeal Carcinomatosis: A Multicenter Prospective Study

Akihiro Tamiya, Motohiro Tamiya, Takashi Nishihara et al. · Anticancer Research · 2017 · 89 citations · Full text

Medicine, Oncology, Pharmacology +16

First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon <i>EGFR</i> Mutations

Yusuke Okuma, Kaoru Kubota, Mototsugu Shimokawa et al. · JAMA Oncology · 2023 · 81 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Real-world effectiveness and safety of nivolumab in patients with non-small cell lung cancer: A multicenter retrospective observational study in Japan

Ryo Morita, Kyoichi Okishio, Junichi Shimizu et al. · Lung Cancer · 2019 · 71 citations · Full text

Medicine, Oncology, Pharmacotherapy +16